Chloroquine for Influenza Prevention (CHIP)

The CHIP trial is testing the possibility that Chloroquine, a simple and well-known medicine, might prevent flu. If this trial shows that Chloroquine works, it would be an ideal medicine to take for flu prevention for several reasons: it is taken by mouth, can be taken only once weekly, and has been in widespread clinical use for over 50 years and is known to be safe. Stay-in is not required for this trial.

To view the CHIP study protocol, please click here

For more information on the CHIP trial, please visit http://www.chip.sg.

Bayer Electrocardiogram Study

This study acts as a positive control for intensive ECG data that has been collected from a prior trial. Its purpose is to validate the ECG assay sensitivity of the equipment used, through administering the drug Moxifloxacin, to healthy subjects. The study consists of 2 periods of treatment with an in-between washout period of 7 days. Stay-in is not required for this trial.

If you are interested in participating in this trial, please contact Ms Toh E Ling or Ms Esther Ong.